Reviewing And Promptness of Publication

SUBMISSION OF MANUSCRIPT:

An online submission and tracking assistance via the Internet helps a rapid and cost-effective submission of manuscripts. The full manuscript must be submitted to Synergy Publishers online via Processing Management System (PMS) Manuscript Processing System (PMS) https://www.synergypublishers.com/pms/.

Kindly submit your paper in MS Word (.doc or .docx / LaTeX) file form according to the full Manuscript Preparation Guides provided later. The number of pages is at the authors’ preference; usually, papers are 10-25 pages long. When developing your article for publication, we strongly suggest paying particular attention to your research methods, key results, and writing. To assure accelerated review and publication, please adhere to these instructions.

It is essential that before submission, authors should thoroughly proofread the files for special characters, scientific symbols, Greek letters, equations, tables, and images, to ensure that they arrive in the proper format.

References, figures, tables, structures, etc., should be written in the text where they have been presented. The author also should give figure legends/captions.

Language:

Provided that the manuscript must be composed in English by the author, and if English is not the author’s parent language, we suggest that the paper be proofed to ensure its effectiveness and improve the language class. The Publisher can further provide copy-editing assistance free of charge.

Originality:

Submissions must be original work, the copyright to which is not earlier published elsewhere. Originality, creativity, and a cross-disciplinary approach or prospects are considerably supported. Unusual duplication of papers and subsequent submissions are not allowed. In such cases, the Publisher reserves the freedom to remove publishing claims from authors and co-authors of the article for an actual time—possible copyright conflict with the copyright holder and consent to our Link to Publication Ethics and Malpractice Statement. Please visit PUBLISHING ETHICS AND INTEGRITY for further details.

COPYRIGHT:

Authors who publish in Lifescience Global Canada Inc. journals retain copyright to their work. Submission of a manuscript to the corresponding journals signifies that all authors have understood and consented to the content of the Covering Letter or the Terms and Conditions. It is a condition of publication that manuscripts presented to a journal have not been published and will not be simultaneously submitted or published elsewhere.

Synergy Publishers (Licensor) grants the author(s) a worldwide, royalty-free, non-exclusive, and persistent non-commercial license to utilize the rights in the article published as declared below:

  • All articles are published supporting the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/legalcode), which allows free distribution and reproduction in any mean that the work is accurately cited.
  • The authors hold the copyright of their published Open Access article. They will also have the right to:
  • Reproduce the article, to include the article into one or more group works, and to reflect the article as incorporated in joint works;
  • Create and reproduce Derivative Works for educational purposes.
  • Distribute Copies
  • With prior agreement by the author, any commercial application of the work is exclusively granted to Lifescience Global Canada Inc.

Download Copyright Form (Link for copyright form)

Preparation of Manuscript:

Manuscripts presented for research and review articles in the corresponding journal should be divided into the following sections:

  • Title
  • Title Page
  • Abstract
  • Keywords
  • Text
  • Conclusion
  • List of Abbreviations (if any)
  • Approval for Publication
  • Availability of Data and Materials
  • Funding
  • Conflict of Interest
  • Acknowledgments
  • References
  • Appendices
  • Figures/Illustrations (if any)
  • Chemical Structures (if any)
  • Tables (if any)
  • Supportive/Supplementary Material (if any)

Title:

The title should be precise and brief and must not be more than 130 words.

Title Page:

The title page should connect article title, author (s) full name and affiliation, corresponding author(s) names absolute affiliation/address, along with phone, fax, and e-mail.

As endorsed by the Reporting guidelines, knowledge about the study should be a part of the title (especially for randomized or clinical trials, comprehensive reviews, and meta-analyses).

Authors should also give a short ‘running title.’ The title, running title, line correspondent footnote, and keywords should be written as presented in the original manuscript.

Abstract:

An article’s abstract should be its clear, concise, and precise summary, should be no more than 250 words, and include the specific sub-headings (as in-line or run-in headings in bold).

The headings can accommodate but must state the study’s goal, details of the members, steps, methods, principal verdicts, and conclusion.

Keywords:

The author must present 5-10 keywords. Keep important and related keywords that researchers in your field will strive for so that your article will appear in a database search. The keywords should contain in the title, and they should seem many times in the article. In biomedical methods, MeSH terms are a large ‘common vocabulary’ reference to draw keywords from https://www.nlm.nih.gov/mesh/meshhome.html.

Text:

The main text should begin on a separate page and be split into the title, abstract, and main text. The text may be partitioned further according to the fields to be presented, backed by the List of Abbreviations (if any), Conflict of Interest, Acknowledgements, and Reference sections. For Review Articles, the manuscript should be arranged into title page, abstract, and the main text. The text may be partitioned considerably according to the fields to continue explained, followed by the Acknowledgements and Reference sections. The Review Article should address any previous notable current and old reviews in the area and include a comprehensive discussion beginning with the general background of the field. It should then go on to discuss the striking features of new advancements. The authors should neglect presenting material that has previously been published in a past review. The authors are advised to show and discuss their observations in summary. Non-assimilated terms from Latin or other languages should be italicized, e.g., per se et al., etc.

For Research Articles, the manuscript should start with the title page and abstract accompanied by the main text, which requires to be structured into separate parts as Introduction, Materials and Methods, Results, Discussion, Conclusion, Ethics Approval, and Consent to Participate, Human and Animal Rights, Conflict of Interest, Acknowledgements, and References.

All randomized clinical examinations must include a flow diagram, and authors should give a finished randomized trial checklist (see CONSORT Flow Diagram and Checklist; www.consort-statement.org) and a test protocol.

For case reports, the authors should understand the CARE guidelines. The CARE checklist should be implemented as a separate file.

The full term for an abbreviation should introduce its first appearance in the text, except it is a standard unit of measure. The reference numbers should be provided in square brackets in the text. Italics should be done for Binomial names of organisms (Genus and Species) for importance and unfamiliar words or phrases.

Introduction:

The Introduction section should combine the background and purposes of the research comprehensively.

Materials and Methods:

This part provides aspects of the methodology used along with knowledge on any previous efforts with corresponding references. The author should add any details for further changes and research. Enough information should be presented to the reader about the original data source to facilitate the analysis, appropriateness, and confirmation of the results reported in the study.

The Method Section needs to be detailed enough concerning the data presented and the results delivered from it. This section should include all the knowledge and protocol selected for the study when it was being written. If the task is funded or financially backed by an organization to conduct the research, it should be considered in the Method Section. Methods must be result-oriented. The declaration regarding the approval by an independent local, regional or national review committee (e.g., the ethics committee and institutional review board) should be part of the Methods Section.

Experimental:

The author should not report repeated knowledge in the text of an article. A calculation section must add experimental data, facts, and practical progress from a theoretical viewpoint.

Results:

The primary findings of the study should appear first in the Results Section. The tables, figures, and references should be presented in sequence to emphasize the vital information or remarks related to the research. The author should bypass the repetition of data in tables and figures. Results should be definite.

Discussion:

The author should investigate the significance of the results of the work and perform a reproducible method. The author should bypass extensive citations and discussion of published research.

The Results and discussions may be performed separately or merged in a single section with short and informational headings.

Conclusion:

The author may give a short paragraph summarising the article’s contents, giving the research outcome, or suggesting further study on the subject at the end of the article under the Conclusion section.

Funding:

The authors need to declare the funding sources of their manuscripts precisely by providing the name of the funding agency or financial support along with the given grant/award number in round brackets (if applied), for instance,

“This work was financially sponsored by [name of the funding agency] (Grant number XXX).

Similarly, if a paper does not have any particular funding source and is part of the authors’ profession, the employer’s name will be expected. Authors will have to state that the funder was involved in writing, editing, approval, or decision to publish the article.

Greek Symbols and Special Characters:

Greek symbols and special characters often undergo formatting differences and get damaged or lost while preparing a manuscript for publication.

Authors are urged to consult reporting guidelines. These guidelines provide a set of instructions comprising a list of items related to their specific research design.

List of Abbreviations (if any):

If abbreviations are utilized in the text, they should be specified where first used, or the author should provide a list of abbreviations.

Appendixes:

If there is a requirement to present long but essential methodological aspects, use appendices, which can be a part of the article. An individual appendix should be titled APPENDIX, while more than one can be titled APPENDIX A, APPENDIX B, and so on.

Supportive/Supplementary Material (if any):

Supportive/Supplementary material proposed for publication must be numbered and referred to in the manuscript but not part of the submitted paper. The author should present In-text citations and a section with the heading “Supportive/Supplementary Material” before the “References” section.

Research Ethics and Policies

Conflict of Interest:

The author must certify financial contributions and any possible conflict of interest under ‘Conflict of Interest.’ Authors need to list the source(s) of funding for the research.

Acknowledgments:

All individuals listed as authors must have dedicated considerably to the conception, execution, analysis, or summarising of the work and are expected to indicate their particular contribution. Anyone (individual/company/institution) who has mainly contributed to studying important intellectual content or drafting or revising the manuscript must also be acknowledged.

Guest or honorary authorship is discouraged based solely on position (e.g., research supervisor, departmental head).

The particular conditions for authorship have been placed by the International Committee of Medical Journal Editors (http://www.icmje.org/).

Human and Animal Rights:

The author should carry all clinical investigations according to the Declaration of Helsinki principles. Formal review and approval by an appropriate institutional review board or ethics committee are required for all manuscripts reporting data from studies involving human participants.

For research affecting animals, the authors should show whether the methods followed the standards outlined in the eighth edition of “Guide for the Care and Use of Laboratory Animals” (grants.nih.gov/grants/olaw/guide-for-the-care-and-use-of-laboratory-animals_prepub.pdf published by the National Academy of Sciences, The National Academies Press, Washington, D.C.).

Research Involving Animals:

Research work on animals should be taken out by the NC3Rs ARRIVE Guidelines. For In Vivo Experiments, please visit https://www.nc3rs.org.uk/arrive-guidelines.

Authors should undoubtedly state the name of the endorsement committee, highlighting that the author achieved legal and ethical consents before initiation of the research work brought out on animals and that handled the tests following the relevant guidelines and regulations stated below.

Research Involving Plants:

All laboratory research on plants (either cultivated or wild) should comply with international guidelines. The manuscript should combine a statement of the agreement of field studies with proper procedures and/or appropriate permissions or licenses obtained by the IUCN Policy Statement on Research Involving Species at Risk of Extinction and the Convention on the Trade in Endangered Species of Wild Fauna and Flora.

Patient Consent:

Compliance with the guidelines of the International Committee of Medical Journal Editors www.icmje.org) is approved, following the patient’s consent for research or assistance in a study as per the relevant laws and regulations regarding the privacy and/or security of personal knowledge, including, but not limited to, the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) and other U.S. federal and state laws describing to confidentiality and security of personally distinct evidence, the General Data Protection Regulation (GDPR) (EU) 2016/679 and member state executing legislation, Canada’s Personal Information Protection and Electronic Documents Act, India’s Information Technology Act and related Privacy Rules, (together “Data Protection and Privacy Laws”).

It is the liability of the author to ensure that:

  • Patients’ names, initials, or hospital numbers are not limited in the manuscript (including figures).
  • Authors are responsible for securing the patient consent-to-disclose forms for all recognizable subjects in photographs, videos, or other information published in the journal, in derivative works, or on the journal’s website and for providing the manuscript to the recognizable patient review before submission.
  • The consent-to-disclose form should show particular use (publication in the medical literature in print and online, knowing that patients and the public will have access) of the patient’s information and images in figures or videos.
  • All such case reports need proper permission to be taken before publishing.

Editors may ask that authors show documentation of the early review and assistance from the institutional review board or ethics committee liable for oversight of the study. The editors reserve the liberty to reject manuscripts that do not comply with the requirements discussed above.

Unethical Behavior:

Anyone may point out unethical practice and misconduct to the Editor and Publisher with enough pieces of evidence. In discussion with the Publisher, the Editor will initiate an investigation against this Unethical misconduct, complete the method until an impartial decision is given, and maintain confidentiality during the research process. The author should be permitted to reply to all minor or major complaints.

In case of severe violations, the employer may be notified by the publishers, where relevant, by the Editor/Publisher, after reviewing all available information and shreds of proof or inquiring help from experts in that field.

Consent for Publication:

If the manuscript has individuals’ data, such as personal detail, audio-video material, etc., the author’s approval should be exercised by the individual. In children’s cases, consent should be taken from the parent or the lawful guardian.

References:

The author should preferably present in the Vancouver style. All references must be complete and accurate. The references should be relevant to the study and should refer to the original research sources. The authors, editors, and peer-reviewers should avoid Self-citation and self-interest.

Below are a few examples of references listed in the Vancouver Style:

Vancouver Style

All references should be numbered sequentially [in square brackets] in the text and placed in the same numerical order in the reference section in Vancouver style. Punctuation should be appropriately applied, as mentioned in the examples given above.

Reference Lists:

Different reference formats have different citation rules. See below for some basic format standards.

Journal Article

The essential information for a journal article is the author’s name, abbreviated journal title, year, publication, volume number, and initial page of cited article, though complete pagination is correct. It is required to list all authors if the total number of authors is six or less, and for more than six authors, use three authors and then et al. (the term “et al.” should be in italics). Journal abbreviations should obey the Index Medicus/MEDLINE. The author needs to capitalize the first letter of the first word in the title. The rest of the title should be in lower-case, except for proper names.

[1] Smith SD, Jones, AD. Organ donation. N Engl J Med 2001; 657: 230-5.

[2] Brown JG. Asphyxiation. Med J Aust 2003; 432:120-4.

Typical Chapter Reference:

[3] Blaxter PS, Farnsworth TP. Social health and class inequalities. In: Carter C, Peel JR, editors. Equalities and inequalities in health. 2nd ed. London: Academic Press 1976; p. 165-78.

Book Reference:

[4] Carlson BM. Human embryology and developmental biology. 3rd ed. St. Louis: Mosby; 2004.

Edited Book:

[5] Brown AM, Stubbs DW, Eds. Medical physiology. New York: Wiley 1983.

Conference Paper and Proceedings:

[6] Anderson JC. Current status of chorion villus biopsy. In: Tudenhope D, Chenoweth J, editors. Proceedings of the 4th Congress of the Australian Perinatal Society; 1986: Brisbane, Queensland: Australian Perinatal Society; 1987: p. 190-6.

[7] Harris AH, Editor. Economics and health: 1997: Proceedings of the 19th Australian Conference of Health Economists; 1997: Sep 13-14; Sydney, Australia. Kensington, N.S.W.: School of Health Services Management, University of New South Wales; 1998.

Journal Article on the Internet:

[8] Aylin P, Bottle A, Jarman B, Elliott, P. Paediatric cardiac surgical mortality in England after Bristol: descriptive analysis of hospital episode statistics 1991-2002. BMJ [serial on the Internet]. 2004 Oct 9;[cited 2004 October 15]; 329:[about 10 screens]. Available from: https://www.bmj.com/content/329/7470/825.full

Book/Monograph on the Internet: 

[9] Dungworth D, Editor. Iron Age and Roman Copper Alloys from Northern Britain [monograph on the Internet]. Washington: Digital Monograph Series; [cited 1997]: Available from https://intarch.ac.uk/journal/issue2/dungworth_index.html.

Web site/Homepage:

[10] Aylin P, Bottle A, Jarman B, Elliott, P. Paediatric cardiac surgical mortality in England after Bristol: descriptive analysis of hospital episode statistics 1991-2002. BMJ [serial on the Internet]. 2004 Oct 9; [cited: 15 October 2004]; 329: [about 10 screens]. Available from: sis.nlm.nih.gov/Tox/ToxMain.html.

Journal with Part/Supplement:

If a journal carries continuous pagination throughout the volume, then the issue number can be omitted.

Issue with Supplement:

[11] Glauser TA. Integrating clinical trial data into clinical practice. Neurology 2002; 58(12 Suppl 7): S6-12.

Volume with Part:

[12] Abend SM, Kulish N. The psychoanalytic method from an epistemological viewpoint. Int J Psychoanal 2002; 83(Pt 2): 491-5.

Issue with Part:

[13] Ahrar K, Madoff DC, Gupta S, Wallace MJ, Price RE, Wright KC. Development of a large animal model for lung tumours. J Vasc Interv Radiol 2002; 13(9 Pt 1): 923-8.

Patent:

[14] Pagedas AC, inventor; Ancel Surgical R&D Inc., assignee. Flexible endoscopic grasping and cutting device and positioning tool assembly. United States patent US 20020103498. 2002 Aug.

E-citations:

[15] Citations for articles/material published exclusively online or in open access (free-to-view) must contain the exact Web addresses (URLs) at the end of the reference(s), except those posted on an author’s Web site unless editorially essential, e.g. ‘Reference: Available from: URL.’

Figures / Tables / Illustrations (if any):

The authors are expected to submit good quality figure(s) in PDF, PPT, MS Word, TIFF, or JPEG versions.

Requirement

  • Width = 8.5 inches (In-between the required size)
  • Height = 11 inches (In-between the required size)

All figures should be in vector scale (except half tone, photograph.)

Chemical Structures:

Chemical structures MUST be prepared in ChemDraw/CDX and provided as a separate file.

Tables:

Data Tables should be presented in Microsoft Word or Excel format.

  • Each table should introduce a title/caption describing the details presented in the table. Detailed legends may then follow.
  • Table number in bold font, i.e., Table 1, should follow a title. The title should be in small case with the first letter in caps.
  • Columns and rows of data should be made visibly distinct by ensuring that the borders of each cell are performed as black lines.
  • Tables should be numbered in Arabic numerals sequentially in order of their citation in the body of the text.
  • Reference cited in both the table and text, please insert a lettered footnote to refer to the numbered reference in the text.
  • It is adequate to present data in Tables to avoid unnecessary repetition and reduce the length of the text.
  • The author must ensure the citation of each table in the text.
  • The author should explain symbols and non-standard abbreviations at the end of the text.
  • All references should be numbered sequentially [in square brackets] in the table and listed in the same numerical order in the reference section.

LANGUAGE AND EDITING:

Manuscripts, including language inconsistencies, will not be published. Authors should ask for professional support for editing grammatical, scientific, and typographical errors before submitting the revised version of the article for publication.

PROOF CORRECTIONS:

Authors are required to proofread the PDF versions of their manuscripts before submission. To avoid delays in publication, proofs should be checked quickly for typographical errors and returned within 48 hours.

The corresponding author will be solely liable for assuring that the revised version of the manuscript, including all the proposed amendments, permits the endorsement of all the manuscript authors.

REVIEWING AND PROMPTNESS OF PUBLICATION

All papers submitted for publication are promptly subjected to preliminary editorial scrutiny by the Editor-in-Chief regarding their appropriateness. The Editor-in-Chief determines if the manuscript:

  • It falls inside the scope of the journal and
  • Meets the editorial standards of Synergy Publishers in terms of originality and quality.

Manuscripts that appear proper are then subjected to double-blind peer-review by, usually three, neutral eminent experts. The services of well-known international experts are sought through invitations to peer-review a submitted manuscript, keeping the manuscript’s scope and the reviewers’ expertise in view. The anonymity of reviewers assures objective and fair assessment of the manuscript by the reviewers.

Before sending the manuscripts to reviewers, Synergy Publishers requests consent from possible reviewers about their availability and willingness to review. Correspondence between the editorial office of the journal and the reviewers is kept secret. The reviewers must provide their reports in a timely fashion since a quick review guides the timely publication of a manuscript beneficial to the authors and the scientific community.

The editorial process and peer-review workflow for each journal are taken care of by a team of Senior Editors, Editorial Board Members (EBMs), and assigned Journal managers who have the needed expertise in their specific fields.

Synergy Publishers takes out a fair review of all articles. The reviewers are sorted according to their expertise from our continually updated referee database.

Based on reviewer comments, the Editors may recommend acceptance, revision, or rejection of a manuscript.

  • Reviewed may be categorized as:
  • Requires minor changes
  • Requires major changes
  • Rejected but may be resubmitted
  • Rejected with no resubmission

Synergy Publishers asks not to have the manuscripts peer-reviewed by the experts who may have a competing concern with the author(s) of a submitted manuscript. Editors can’t be notified of all competing interests; therefore, it is expected that the reviewers would inform the Editor-in-Chief/Handling Editor if they see any potential competing interest as the review of a manuscript.

The authors usually are requested to resubmit the revised paper within one week, and it will then be passed to the reviewers for further evaluation by the publishers. The Editor-in-Chief of the journal is the final authority to accept or reject the manuscript.

  • The average time during which the preliminary assessment of manuscripts is conducted in 5 Days
  • The average time during which the reviews of manuscripts are conducted in 45 Days
  • The average time in which the article is published 60 Days

PUBLICATION CHARGES POLICY:

Synergy Publishers is obliged to disseminate research and scholarly publications as broadly as possible. It supports the principle that ‘the study results that have been publicly funded should be freely available in the public domain. Therefore, it helps researchers to make their research ready through Open Access (OA).

Open access publishing is not without costs. Synergy Publishers provides open access publications that partially pay the expenses of journal production, online hosting, and archiving from authors and their research supporters by charging a publication fee for each article they publish. Visit: PUBLICATION CHARGES for further details.

SPECIAL FEE WAIVERS:

Synergy Publishers allows waivers and discounts to those corresponding authors based in low-income countries.

50% FEE waiver to authors from any countries, which the World Bank classified as Low-income economies as 2021. Please visit FEE WAIVERS for further details.

PLAGIARISM PREVENTION

Synergy Publishers functions the iThenticate software, which identifies instances of overlapping and similar text in submitted manuscripts. This software checks content against a database of publications, the Internet, and an extensive article database. It creates a similarity report, highlighting the percentage overlap between the uploaded article and the published stuff. Visit: PLAGIARISM PREVENTION for further details

Synergy Publishers indeed follow the COPE guidelines to identify plagiarism; for more precise insight, authors may refer to flow charts given by COPE.

APPEALS AND COMPLAINTS:

Usually, the editorial judgments are not reverted. Authors who believe that manuscript was declined due to a misunderstanding or error may seek an answer for the decision. Appeals must provide sound reasoning, and compelling proof against the analysis suggested in the rejection letter. A diversity of opinion, interest, novelty, or appropriateness of the manuscript for the journal will not be known as an appeal. The EIC and other related editors will examine the application, and the judgment after that taken by the journal will be considered final. Acceptance of the manuscript is not insured even if the journal agrees to consider the manuscript. The reconsideration process may include past or new reviewers or editors and substantive revision.

Authors who wish to make a complaint should refer them to the Editor-in-Chief of the journal concerned. Synergy Publishers is constantly aiming to develop its publication practices. If you are not convinced with any procedure of the processing of your manuscript, then please let us know at the following e-mail address with full details:

Please get in touch with managing.editor@synergypublishers.com for assistance.

REPRINTS:

Synergy Publishers produces the best professionally printed reprints. The minimum limit of reprint orders is 100 copies.

PRINTED COVERS:

Printed covers are available at extra cost.

Please visit: managing.editor@synergypublishers.com

PERMISSION FOR REPRODUCTION:

Published/reproduced material should not be covered unless you have gained written consent from the copyright holder.

For obtaining permission for reproducing any material published in an article by Synergy Publishers managing.editor@synergypublishers.com for consideration.

CONFERENCE PROCEEDINGS:

For projects to publish conference proceedings in this journal, e-mail us at: managing.editor@synergypublishers.com.